News

The final day of Prohibition Partners Live was about Business and Investment with not only the movement of US firms into overseas markets – especially Europe – but also the internationalisation and globalisation of cannabis.

In his opening address to day three, Prohibition Partners’ CEO Stephen Murphy outlined the agenda and said two key topics that would be covered would be capital and the rise of celebrity brands and endorsement.

Proceedings will get underway at 12:00pm (BST) with a Pre-Event Networking Session where you can connect with and send contact requests to other attendees and schedule 1:1 private meetings within the platform.

This will be followed by a special live Prohibition Partners Consulting Roundtable on the Cannabis Europa stage. Chaired by Prohibition Partners’ consulting director, Barbara Pastori, it will home in on business and investment as firms seek the tools to navigate and prosper in the cannabis industry.

With more than 1,500 people attending Day 2 of Prohibition Partners LIVE, CEO and co-founder Stephen Murphy welcomed everyone to the event, the focus of which was Policy and Reform.

This, he said, would take in everything from the future of the industry to EU regulations and guidance, what this would mean for the UK where “the previous hot potato that cannabis was in a political sense is no longer there,” to potentially uncomfortable conversations about lack of diversity and social equality, sustainability, and the possible end of prohibition, which Mr Murphy joked could mean “we will have to change our name!”.

The focus for Day Two is Policy and Reform, beginning at 12:50pm (BST). Our first session of the day at 12:50pm (BST) will be Cannabis Europa 2021 – The Return of Events. What might the next series of industry events look like and who will be able to attend?

OVER the next three days, Prohibition Partners LIVE features a packed programme of discussion and debate featuring some of the global cannabis industry’s most informed leaders and opinion-makers.

The focus on Day One is on Science, Research and Technology and begins at midday with both VIP Pre-Event, and pre-event networking sessions, followed by an opening address from Prohibition Partners Co-Founder, Stephen Murphy.

OVER the next three days, Prohibition Partners LIVE features a packed programme of discussion and debate featuring some of the global cannabis industry’s most informed leaders and opinion-makers.

The focus on Day One is on Science, Research and Technology and begins at midday with both VIP Pre-Event, and pre-event networking sessions, followed by an opening address from Prohibition Partners Co-Founder, Stephen Murphy.

Prohibition Partners LIVE is happy to announce Grass & Co., a leading British CBD and botanicals brand, as a main sponsor for the first event of the year, taking place on 18-20 May.

Born out of extensive and detailed data and consumer research into the established North American CBD markets, Grass & Co. was launched in the UK to champion the benefits of CBD and make it relevant and accessible to all within the mainstream market.

Returning as a Prohibition Partners LIVE sponsor for the second year running, CanX CBD Processing Corp is a global leader in cannabis extraction, biomass cultivation, and manufacturing wholesale CBD derivatives. From cultivating and harvesting biomass to state-of-the-art ethanol extraction, CanX CBD covers the entire CBD supply and distribution chain—farming, processing, shipping, customer service, and logistics.

Prohibition Partners LIVE is pleased to announce WeedMD, a leading Candian federally-licensed producer of cannabis products, as a main sponsor for the first event of the year, taking place on 18-20 May.

WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders, producing and distributing premium cannabis products for both the medical and adult-use markets.

Prohibition Partners LIVE is proud to announce Global Cannabis Applications Corp. (GCAC), a leading developer of innovative data technologies for the medical cannabis industry, as a main sponsor for the first event of the year, taking place on 18-20 May.

GCAC’s innovative Ethereum-powered platform, Citizen Green Efixii, aims to solve one of the principal pain points for medical cultivators and consumers alike – the compliance, authentication, tracking, and certification of products to ensure quality, consistency, and most importantly, efficacy.